Advocacy

JDRF Advocates help build and sustain critical support for type 1 diabetes (T1D) research funded by the Federal Government by raising awareness among Members of Congress of the financial, medical and emotional costs of the disease.

https://www.jdrf.org/wp-content/uploads/2018/10/Advocacy_hero_square-1.jpg

Take Action

Use your voice to help secure continued Federal funding for important diabetes research, inform health and regulatory policy, and improve the quality of life for those affected by T1D – until we find a cure.

The Issues

Learn more about policies and programs that impact the T1D community.

Advocacy Agenda

JDRF has set an ambitious advocacy agenda for 2020 to ensure people have access to the most effective T1D treatments and therapies.

Learn More

Improving Lives

JDRF is committed to accelerating the development of drugs and devices that enable people with T1D to live longer, healthier lives, including next generation artificial pancreas systems.

Learn More

Federal Funding

JDRF strongly advocates for the highest possible funding levels for the National Institutes of Health (NIH) and U.S. Food and Drug Administration (FDA).

Learn More

Healthcare Principles

JDRF is fighting for protections for pre-existing conditions and other health reform principles.

Learn More

Insulin Access and Innovation

JDRF is committed to making insulin more affordable and accessible, while ensuring the next generation of insulins continue to develop.

Learn More

Medicare Coverage

Thanks to extensive advocacy by JDRF and other stakeholders and strong bipartisan support from Congress, continuous glucose monitors (CGM) are now eligible for Medicare coverage.

Learn More

Special Diabetes Program

Our advocacy helped secure nearly $2.8 billion for T1D research since 1997 through the Special Diabetes Program (SDP).

Learn More

T1D Outcomes Program

JDRF is working with the community to better define clinical meaningful T1D outcomes beyond HbA1c.

Learn More

Biosimilar Insulin Principles

JDRF is encouraging health plans, employer benefit administrators, and regulators to adopt these principles, which will ensure patients and providers are supported in the rollout of insulin biosimilars.

Learn More

What is Grassroots Advocacy?

Writing and Calling

Members of Congress through initiatives

Meeting

with lawmakers and their staff

Telling

our stories of living with T1D

Inspiring

others to raise their voices

Become an Advocate

https://www.jdrf.org/wp-content/uploads/2018/10/TakeAction_1200x800.jpg